Brief: Cytek Biosciences Q4 Revenue USD 58.6 Million Vs. IBES Estimate USD 56.6 Million
28/02/2024 22:06
Feb 28 (Reuters) - Cytek Biosciences Q4 adjusted EBITDA USD 10.963 million. * Q4 net income USD 6.3 million * outlook FY revenue USD 203-213 million
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million